XML 22 R15.htm IDEA: XBRL DOCUMENT v3.21.2
Equity method investments
 9 Months Ended
Sep. 30, 2021
Equity Method Investments and Joint Ventures [Abstract]  
Equity method investments Equity method investmentsThe Company has invested $4.9 million to obtain a 49% interest in the voting share capital of Oncacare Limited ("Oncacare"). The Company’s investment in Oncacare is accounted for under the equity method due to the Company's ability to exercise significant influence over Oncacare that is considered to be greater than minor. The Company records its pro rata share of the earnings/losses of this investment in 'Share of equity method investments' in the Condensed Consolidated Statement of Operations.
The majority investor has the right to sell the 51% majority voting share capital exclusively to the Company in a two and half year period commencing from January 1, 2023 and ICON also has the right to acquire the 51% majority voting share capital from August 1, 2025.

The following table represents our equity method investments at September 30, 2021:
Ownership PercentageCarrying ValueCarrying Value
September 30, 2021September 30, 2021December 31, 2020
(in thousands)
Oncacare Limited49 %$3,062 $4,534 

The Company has recorded a loss of $0.7 million representing its pro rata share of the losses in Oncacare for the three month period ended September 30, 2021. The Company recorded a loss of $1.5 million for the nine months ended September 30, 2021.